

FDA Authorizes New Long-Acting, Monoclonal Antibodies for Pre-exposure Prevention of COVID-19 in Certain Individuals

Considerations for Prescribing Avacopan for ANCA-Associated Vasculitis

FDA Grants Octapharma 7-Year Market Exclusivity for Octagam 10%

FDA Approves IVIG to Treat Adults with Dermatomyositis
AbbVie, Lilly Face New Delays in FDA Approval for Expanded Use of Janus Kinase Inhibitors

14 Rheumatology Treatments Make Top 50 List of Drugs That Can Cause Anaphylaxis

FDA Approves Tocilizumab to Treat Systemic Sclerosis-Associated ILD

FDA Approves Belimumab & Voclosporin for Lupus Nephritis

Health Canada Approves CT-P13 SC for RA; Plus Tofacitinib May Increase Cardiac & Cancer Risks
- 1
- 2
- 3
- …
- 27
- Next Page »